Celerion https://validator.w3.org/feed/docs/rss2.html Jo Goodman Joins Celerion as Vice President of Bioanalytical Services Key Clinical Pharmacology Studies to Support Biologic Drug Regulatory Submission Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year  Celerion’s US Pharmacies Expand On-Site Services, Ensure cGMP FDA Compliance for Phase 1 Investigational Drugs How Healthy Volunteer Studies can Accelerate Oncology Drug Development GLP-1 Agonist-Induced Delayed Gastric Emptying – A Clinical Pharmacology Perspective Celerion Pledges Commitment to the Science-Based Targets Initiative (SBTi) Net-Zero Standard Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center  Reframing the Definition of Obesity Ruling the Future: How the ACLA’s LDT Court Victory and Europe’s IVDR Are Shaping Bioanalytical Laboratories FDA Endorses Human-Relevant Nonclinical Models: A Welcome Shift for Monoclonal Antibody Development Smarter, Faster, Safer: Celerion Unveils Major Upgrade to LabNotes Bioanalytical Software Rethinking Drug Development: The Role of Model-Informed Approaches in Advancing Cell and Gene Therapies Without Animal Testing Celerion Launches Enhanced Version of Labnotes Bioanalytical Data Management Software  The Rising Tide of Weight Reduction Therapies Celerion Earns AAHRPP Full Reaccreditation for Five Years, Strengthening Commitment to Ethical Research Practices PBMCs or Whole Blood? Strategic Applications in Phase I Studies Celerion Welcomes Dr. Steven Evans as Senior Cardiologist to Enhance Cardiovascular Safety in Clinical Trials Clinical Data Science Services The Resurgence of Antibody Drug Conjugates: How ADCs are taking over oncology (again) and what we’ve learned about creating bioanalytical methods to support preclinical and clinical success. Home 12 Questions to Help Guide Renal Impairment PK Study Design Sinus Arrest Associated with COVID-19 Nasalpharyngeal Swab Procedure Application of Ophthalmic Examinations In Early Phase Studies Application of Echocardiograms In Early Phase Studies 2026 ObesityWeek 2026 EBF Open Symposium 2026 Coresta Congress 2026 AAPS PharmSci 360 2026 Immunogenicity Summit 2026 World ADC San Diego 2026 Mass Spectrometry & Advances in the Clinical Lab (MSACL) Annual Conference 2026 ACCP Annual Meeting 2026 21st Applied Pharmaceutical Analysis (APA) Conference 2026 EBF Autumn Focus Workshop 2026 AAPS Summer Scientific Forum Celerion Overview Brochure 𝗧𝗵𝗲 𝗠𝗮𝗻𝘆 𝗙𝗮𝗰𝗲𝘀 𝗼𝗳 𝗕𝗶𝗼𝗲𝗾𝘂𝗶𝘃𝗮𝗹𝗲𝗻𝗰𝗲 2026 AAPS NBC 2026 American Society for Mass Spectrometry 2026 EBF Spring Focus Workshop 2026 CYTO 2026 EBF YSS 2026 SLAS Europe 2026 Gyrolab Seminar 2026 Swiss Biotech Day Careers No More Guesswork: The Ideal eGFR Formula for Optimized Healthy Volunteer Study Enrollment QT Myopia and Cardiac Safety About